Mammography Market (By Product: Film Screen Systems, Digital Systems, Analog Systems, Biopsy Systems, 3D Systems, Others; By Technology: Breast Tomosynthesis Mammography,CAD Mammography, Digital Mammography; By Modality: Portable, Non-Portable; By End Use: Hospitals, Special Clinics, Diagnosis Centers, Ambulatory Surgical Centers, Educational & Research Institutes) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2023-2032
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Mammography Market
5.1. COVID-19 Landscape: Mammography Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Mammography Market, By Product
8.1. Mammography Market, by Product, 2023-2032
8.1.1. Film Screen Systems
8.1.1.1. Market Revenue and Forecast (2020-2032)
8.1.2. Digital Systems
8.1.2.1. Market Revenue and Forecast (2020-2032)
8.1.3. Analog Systems
8.1.3.1. Market Revenue and Forecast (2020-2032)
8.1.4. Biopsy Systems
8.1.4.1. Market Revenue and Forecast (2020-2032)
8.1.5. 3D Systems
8.1.5.1. Market Revenue and Forecast (2020-2032)
8.1.6. Others
8.1.6.1. Market Revenue and Forecast (2020-2032)
Chapter 9. Global Mammography Market, By Technology
9.1. Mammography Market, by Technology e, 2023-2032
9.1.1. Breast Tomosynthesis Mammography
9.1.1.1. Market Revenue and Forecast (2020-2032)
9.1.2. CAD Mammography
9.1.2.1. Market Revenue and Forecast (2020-2032)
9.1.3. Digital Mammography
9.1.3.1. Market Revenue and Forecast (2020-2032)
Chapter 10. Global Mammography Market, By Modality
10.1. Mammography Market, by Modality, 2023-2032
10.1.1. Portable
10.1.1.1. Market Revenue and Forecast (2020-2032)
10.1.2. Non-Portable
10.1.2.1. Market Revenue and Forecast (2020-2032)
Chapter 11. Global Mammography Market, By End Use
11.1. Mammography Market, by End Use, 2023-2032
11.1.1. Hospitals
11.1.1.1. Market Revenue and Forecast (2020-2032)
11.1.2. Special Clinics
11.1.2.1. Market Revenue and Forecast (2020-2032)
11.1.3. Diagnosis Centers
11.1.3.1. Market Revenue and Forecast (2020-2032)
11.1.4. Ambulatory Surgical Centers
11.1.4.1. Market Revenue and Forecast (2020-2032)
11.1.5. Educational & Research Institutes
11.1.5.1. Market Revenue and Forecast (2020-2032)
Chapter 12. Global Mammography Market, Regional Estimates and Trend Forecast
12.1. North America
12.1.1. Market Revenue and Forecast, by Product (2020-2032)
12.1.2. Market Revenue and Forecast, by Technology (2020-2032)
12.1.3. Market Revenue and Forecast, by Modality (2020-2032)
12.1.4. Market Revenue and Forecast, by End Use (2020-2032)
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Product (2020-2032)
12.1.5.2. Market Revenue and Forecast, by Technology (2020-2032)
12.1.5.3. Market Revenue and Forecast, by Modality (2020-2032)
12.1.5.4. Market Revenue and Forecast, by End Use (2020-2032)
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Product (2020-2032)
12.1.6.2. Market Revenue and Forecast, by Technology (2020-2032)
12.1.6.3. Market Revenue and Forecast, by Modality (2020-2032)
12.1.6.4. Market Revenue and Forecast, by End Use (2020-2032)
12.2. Europe
12.2.1. Market Revenue and Forecast, by Product (2020-2032)
12.2.2. Market Revenue and Forecast, by Technology (2020-2032)
12.2.3. Market Revenue and Forecast, by Modality (2020-2032)
12.2.4. Market Revenue and Forecast, by End Use (2020-2032)
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Product (2020-2032)
12.2.5.2. Market Revenue and Forecast, by Technology (2020-2032)
12.2.5.3. Market Revenue and Forecast, by Modality (2020-2032)
12.2.5.4. Market Revenue and Forecast, by End Use (2020-2032)
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Product (2020-2032)
12.2.6.2. Market Revenue and Forecast, by Technology (2020-2032)
12.2.6.3. Market Revenue and Forecast, by Modality (2020-2032)
12.2.6.4. Market Revenue and Forecast, by End Use (2020-2032)
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Product (2020-2032)
12.2.7.2. Market Revenue and Forecast, by Technology (2020-2032)
12.2.7.3. Market Revenue and Forecast, by Modality (2020-2032)
12.2.7.4. Market Revenue and Forecast, by End Use (2020-2032)
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Product (2020-2032)
12.2.8.2. Market Revenue and Forecast, by Technology (2020-2032)
12.2.8.3. Market Revenue and Forecast, by Modality (2020-2032)
12.2.8.4. Market Revenue and Forecast, by End Use (2020-2032)
12.3. APAC
12.3.1. Market Revenue and Forecast, by Product (2020-2032)
12.3.2. Market Revenue and Forecast, by Technology (2020-2032)
12.3.3. Market Revenue and Forecast, by Modality (2020-2032)
12.3.4. Market Revenue and Forecast, by End Use (2020-2032)
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Product (2020-2032)
12.3.5.2. Market Revenue and Forecast, by Technology (2020-2032)
12.3.5.3. Market Revenue and Forecast, by Modality (2020-2032)
12.3.5.4. Market Revenue and Forecast, by End Use (2020-2032)
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Product (2020-2032)
12.3.6.2. Market Revenue and Forecast, by Technology (2020-2032)
12.3.6.3. Market Revenue and Forecast, by Modality (2020-2032)
12.3.6.4. Market Revenue and Forecast, by End Use (2020-2032)
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Product (2020-2032)
12.3.7.2. Market Revenue and Forecast, by Technology (2020-2032)
12.3.7.3. Market Revenue and Forecast, by Modality (2020-2032)
12.3.7.4. Market Revenue and Forecast, by End Use (2020-2032)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Product (2020-2032)
12.3.8.2. Market Revenue and Forecast, by Technology (2020-2032)
12.3.8.3. Market Revenue and Forecast, by Modality (2020-2032)
12.3.8.4. Market Revenue and Forecast, by End Use (2020-2032)
12.4. MEA
12.4.1. Market Revenue and Forecast, by Product (2020-2032)
12.4.2. Market Revenue and Forecast, by Technology (2020-2032)
12.4.3. Market Revenue and Forecast, by Modality (2020-2032)
12.4.4. Market Revenue and Forecast, by End Use (2020-2032)
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Product (2020-2032)
12.4.5.2. Market Revenue and Forecast, by Technology (2020-2032)
12.4.5.3. Market Revenue and Forecast, by Modality (2020-2032)
12.4.5.4. Market Revenue and Forecast, by End Use (2020-2032)
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Product (2020-2032)
12.4.6.2. Market Revenue and Forecast, by Technology (2020-2032)
12.4.6.3. Market Revenue and Forecast, by Modality (2020-2032)
12.4.6.4. Market Revenue and Forecast, by End Use (2020-2032)
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Product (2020-2032)
12.4.7.2. Market Revenue and Forecast, by Technology (2020-2032)
12.4.7.3. Market Revenue and Forecast, by Modality (2020-2032)
12.4.7.4. Market Revenue and Forecast, by End Use (2020-2032)
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Product (2020-2032)
12.4.8.2. Market Revenue and Forecast, by Technology (2020-2032)
12.4.8.3. Market Revenue and Forecast, by Modality (2020-2032)
12.4.8.4. Market Revenue and Forecast, by End Use (2020-2032)
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Product (2020-2032)
12.5.2. Market Revenue and Forecast, by Technology (2020-2032)
12.5.3. Market Revenue and Forecast, by Modality (2020-2032)
12.5.4. Market Revenue and Forecast, by End Use (2020-2032)
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Product (2020-2032)
12.5.5.2. Market Revenue and Forecast, by Technology (2020-2032)
12.5.5.3. Market Revenue and Forecast, by Modality (2020-2032)
12.5.5.4. Market Revenue and Forecast, by End Use (2020-2032)
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Product (2020-2032)
12.5.6.2. Market Revenue and Forecast, by Technology (2020-2032)
12.5.6.3. Market Revenue and Forecast, by Modality (2020-2032)
12.5.6.4. Market Revenue and Forecast, by End Use (2020-2032)
Chapter 13. Company Profiles
13.1. Hologic
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Fujifilm
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Siemens Healthcare
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Phillips Healthcare
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. Toshiba Medical Systems
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. GE Healthcare
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Metaltronica
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. I.M.S. Srl
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. Koninklijke Philips NV
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. Gamma Medica, Inc
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
Chapter 14. Research Methodology
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
Chapter 15. Appendix
15.1. About Us
15.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client